 |
Code of Federal Regulations (Last Updated: November 8, 2024) |
 |
Title 21 - Food and Drugs |
|
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
|
SubChapter D - Drugs for Human Use |
|
|
Part 330 - Over-the-Counter (OTC) Human Drugs Which Are Generally Recognized as Safe and Effective and Not Misbranded |
Part 330 - Over-the-Counter (OTC) Human Drugs Which Are Generally Recognized as Safe and Effective and Not Misbranded
| Subpart A - General Provisions |
| § 330.1 - General conditions for general recognition as safe, effective and not misbranded. |
| § 330.2 - Pregnancy-nursing warning. |
| § 330.3 - Imprinting of solid oral dosage form drug products. |
| § 330.5 - Drug categories. |
| Subpart B - Administrative Procedures |
| § 330.10 - Procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded, and for establishing monographs. |
| § 330.11 - NDA deviations from applicable monograph. |
| § 330.12 - Status of over-the-counter (OTC) drugs previously reviewed under the Drug Efficacy Study (DESI). |
| § 330.13 - Conditions for marketing ingredients recommended for over-the-counter (OTC) use under the OTC drug review. |
| § 330.14 - Additional criteria and procedures for classifying OTC drugs as generally recognized as safe and effective and not misbranded. |
| § 330.15 - Timelines for FDA review and action on time and extent applications and safety and effectiveness data submissions. |